Liver & Digestive Health

The UCLPartners Liver and Digestive Health Programme concentrates on maintaining and enhancing a healthy condition of the digestive system, and on treating its dysfunctions and diseases, in both children and adults.

We are devoted to the study and treatment of the digestive system in three main domains: insufficiency of the liver; intestinal failure; and digestive, liver and pancreatico-biliary tumours.

In addition, our Programme places particular emphasis on education, as well as on the performance of randomized clinical trials in liaison with the NIHR and other national research agencies. The Programme is built on the contribution of health operators, scientists and teachers involved with basic and clinical science.

Liver health and insufficiency

Our work on liver health and insufficiency focuses on the study of cirrhosis, viral hepatitis, and alcoholic liver disease in adolescents and adults. One important focus is the prevention and treatment of liver failure following liver surgery/transplantation. The study of portal hypertension, the improvement of survival after upper gastro-intestinal (GI) bleeding, is a key priority  of this programme.

Intestinal failure and health

The intestinal failure and health programme focuses on the optimal maintenance of nutritional status in the healthy individual, as well as on critical intestinal conditions. Intestinal insufficiency in the newborn and in small children is a specific element of this programme. The Inflammatory Bowel Disease (IBD) programme concentrates on the etiology and treatment of these conditions both in the adolescent and adult population.

Gastro-intestinal and liver cancer

The GI and liver cancer program focuses on the prevention and screening of gastro-intestinal tumours. In addition we target the treatment of rare cancers of the liver and of the pancreatico-biliary tract.

For more information, please contact Professor Max Malago’, Director of Liver and Digestive Health at UCLPartners.